Robert Wood Johnson Foundation   Report issue

Foundation Phase 4
Founded: Princeton NJ United States (1972)

Organization Overview

First Clinical Trial
2004
NCT00565916
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Robert Wood Johnson Foundation